As mandated by the Kay Hagan Tick Act, signed into law in 2019 as part of the FY 2020 Further Consolidated Appropriations Act, OASH is working closely with CDC to develop a National Strategy to address Vector-Borne Diseases carried by ticks and other blood-feeding vectors.
The National Strategy will identify:
- gaps and unnecessary duplication in federally funded programs
- strategic goals to address vector-borne diseases
- benchmarks to measure progress toward achieving such goals
The National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans (CDC, 2020) lays a foundation for developing and executing a full National Strategy that details the activities needed to accomplish the articulated goals.
